AAAAAA
Results:
1-16
|
Results: 16
Authors:
Althaus, M
de Mey, C
Ezan, E
Ciecko-Michalska, I
Kostka-Trabkal, E
Goszcz, A
Retzow, A
Citation: M. Althaus et al., Plasma and urine, pharmacokinetics of the dopamine agonist alpha-dihydroergocryptine in patients with hepatic dysfunction, INT J CL PH, 39(2), 2001, pp. 67-74
Authors:
Minea, D
Varga, I
Falup-Pecurariu, C
de Mey, C
Retzow, A
Althaus, M
Citation: D. Minea et al., Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's disease, CLIN NEUROP, 24(4), 2001, pp. 235-238
Authors:
de Mey, C
Citation: C. De Mey, Long-term goals in the treatment of lower urinary tract symptoms, DRUGS TODAY, 37, 2001, pp. 39-46
Authors:
de Mey, C
Althaus, M
Ezan, E
Retzow, A
Citation: C. De Mey et al., Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans, CLIN PHARM, 70(2), 2001, pp. 142-148
Authors:
de Mey, C
Citation: C. De Mey, Sense and nonsense of post-authorization surveillance, MED KLIN, 95(1), 2000, pp. 56-62
Authors:
de Mey, C
Citation: C. De Mey, Sense and nonsense of post-authorization surveillance, MED KLIN, 95, 2000, pp. 77-82
Authors:
Kunkel, G
Magnussen, H
Bergmann, KC
Juergens, UR
de Mey, C
Freund, E
Hinzmann, R
Becker, B
Citation: G. Kunkel et al., Respimat (R) (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients, RESPIRATION, 67(3), 2000, pp. 306-314
Authors:
de Mey, C
Citation: C. De Mey, Latest results of long-term benefits of tamsulosin on the prostate and bladder, DRUGS TODAY, 36, 2000, pp. 11-14
Authors:
Matthys, H
de Mey, C
Carls, C
Rys, A
Geib, A
Wittig, T
Citation: H. Matthys et al., Efficacy and Tolerability of Myrtol Standardized in Acute Bronchitis - A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol, ARZNEI-FOR, 50(8), 2000, pp. 700-711
Authors:
Retzow, A
Althaus, M
de Mey, C
Mazur, D
Vens-Cappell, B
Citation: A. Retzow et al., Study on the interaction of the dopamine agonist alpha-dihydroergocryptinewith the pharmacokinetics of digoxin, ARZNEI-FOR, 50(7), 2000, pp. 591-596
Authors:
Kiesewetter, H
Koscielny, J
Kalus, U
Vix, JM
Peil, H
Petrini, O
van Toor, BSJ
de Mey, C
Citation: H. Kiesewetter et al., Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II) - A randomized,double-blind, placebo-controlled trial, ARZNEI-FOR, 50(2), 2000, pp. 109-117
Authors:
Schafers, RF
Fokuhl, B
Wasmuth, A
Schumacher, H
Taguchi, K
de Mey, C
Philipp, T
Michel, MC
Citation: Rf. Schafers et al., Differential vascular alpha(1)-adrenoceptor antagonism by tamsulosin and terazosin, BR J CL PH, 47(1), 1999, pp. 67-74
Authors:
de Mey, C
Citation: C. De Mey, alpha(1)-blockers for BPH: Are there differences?, EUR UROL, 36, 1999, pp. 52-63
Authors:
Meister, R
Wittig, T
Beuscher, N
de Mey, C
Citation: R. Meister et al., Efficacy and tolerability of myrtol standardized in long-term treatment ofchronic bronchitis - A double-blind, placebo-controlled study, ARZNEI-FOR, 49(4), 1999, pp. 351-358
Authors:
de Mey, C
Citation: C. De Mey, Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: Impact on safety and well-being (vol 34, pg 18, 1998), EUR UROL, 34(6), 1998, pp. 527-527
Authors:
de Mey, C
Citation: C. De Mey, Opportunities for the treatment of erectile dysfunction by modulation of the NO axis - Alternatives to sildenafil citrate, CURR MED R, 14(4), 1998, pp. 187-202
Risultati:
1-16
|